Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.
提供了调节C5a受体的化合物。这些化合物是取代
二氢吡啶,并可用于制药组合物、治疗涉及C5a受体病理性激活的疾病和障碍的方法。